In vivo, expression of TLR4, TIRAP, MyD88, TRAF6, p38, NEMO, and IRF5 in PBMCs in the PAD model group was higher than that in the control group and sham-operation group. The gene discussed is MAPK14; the disease is peripheral arterial disease.